Khushali Jhaveri, Assistant Professor of Medicine at IU Simon Comprehensive Cancer Center, shared a post on X:
“In lymphoma, progress feels rapid.
Yet only ~6% of drugs entering phase I reach approval, most lost before phase III.
As a junior faculty member, that’s a sobering reality.
Important paper in Blood Advances.”
Title: Clinical trial success rate in lymphoma: fate of trials and agents from 2000 to 2019.
Authors: Zhiping Luo, Meng Li, Brian C. Primeaux, Rahul Shah, Ruitao Lin, Swaminathan P. Iyer, Loretta J. Nastoupil, Michael R. Green, Jason R. Westin, Christopher R. Flowers, Dai Chihara
Read The Full Article
Other articles featuring Khushali Jhaveri on OncoDaily.